Effect of Click Chemistry Linkages on the Biological Behavior of Albumin-Binding 177 Lu-DOTAGA-pIBA-LLP2A Analogues Targeting Melanoma
Bioconjugate Chemistry · 2025
DOI: 10.1021/acs.bioconjchem.5c00277 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioconjugate Chemistry, 2025. Verfasst von Longbo Li und 11 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Imaging and Theranostics Center, University of Missouri, Columbia, Missouri 65211, United States. Hauptthemen laut MEDLINE: Click Chemistry, Lutetium, Melanoma, Albumins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: NCI NIH HHS, Division of Cancer Prevention, National Cancer Institute, University of Missouri.
Abstract (Originalsprache)
The transmembrane integrin, very late antigen-4 (VLA-4), which is a critical integrin involved in promoting tumor progression, angiogenesis, and metastasis, is overexpressed in metastatic melanoma. The peptidomimetic LLP2A has a high binding affinity to VLA-4 and is used as a radiopharmaceutical targeting agent for imaging and therapy. Previous studies demonstrated that the albumin-binding compound, [177Lu]Lu-DOTAGA-pIBA-PEG4-LLP2A, significantly improved tumor retention and blood circulation time but resulted in lower tumor-to-nontumor tissue ratios compared to the nonalbumin-binding compound, [177Lu]Lu-DOTAGA-PEG4-LLP2A. To streamline the synthesis of VLA-4 targeting molecules as therapeutic agents and allow a modular approach, we investigated three click chemistry linkers for preparing DOTAGA-pIBA-PEG4-LLP2A analogues: [177Lu]Lu-DOTAGA-pIBA-TCO-tetrazine-PEG4-LLP2A ([177Lu]Lu-1), [177Lu]Lu-DOTAGA-pIBA-BCN-azide-PEG4-LLP2A ([177Lu]Lu-2), and [177Lu]Lu-DOTAGA-pIBA-DBCO-azide-PEG4-LLP2A ([177Lu]Lu-3). Determining the click linkage that provides optimal synthesis ease and pharmacokinetics will allow us to readily produce additional VLA-4 targeting radiopharmaceuticals. Saturation binding assays demonstrated high binding affinity of [177Lu]Lu-1, [177Lu]Lu-2, and [177Lu]Lu-3 to VLA-4 in B16F10 cells, with Kd = 1.2 ± 0.2, 0.8 ± 0.4, and 1.6 ± 0.5 nM, respectively. Biodistribution of [177Lu]Lu-1 showed peak tumor uptake at 24 h (12.2 ± 0.7%IA/g) and retention to 96 h (9.5 ± 1.7%IA/g), while [177Lu]Lu-2 peaked at 48 h (13.5 ± 2.2%IA/g) and gradually decreased (9.93 ± 3.3%IA/g at 96 h). [177Lu]Lu-3 peaked at 48 h (16.9 ± 3.9%IA/g) and was retained to 96 h (14.8 ± 3.8%IA/g). Compared with [177Lu]Lu-1 and [177Lu]Lu-3, [177Lu]Lu-2 cleared more rapidly from normal tissues. [177Lu]Lu-2 showed higher tumor-to-kidney ratios compared to [177Lu]Lu-1 at all time points and higher tumor-to-liver ratios up to 96 h. [177Lu]Lu-2 also showed higher tumor-to-liver ratios compared to [177Lu]Lu-3 up to 48 h. The tumor can be clearly visualized with all compounds using SPECT/CT. The BCN click linkage ([177Lu]Lu-2) will be applied in future compounds with other targeting ligands, radionuclides, albumin binders, and chelators.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Molecular Imaging and Theranostics Center, University of Missouri, Columbia, Missouri 65211, United States.
- Department of Chemistry, University of Missouri, Columbia, Missouri 65211, United States.
- Molecular Interactions Core, University of Missouri, Columbia, Missouri 65211, United States.
- University of Missouri Research Reactor Center, University of Missouri, Columbia, Missouri 65211, United States.
- Research Division, Harry S. Truman Memorial Veterans' Hospital, Columbia, Missouri 65211, United States.
- Ellis Fischel Cancer Center, University of Missouri, Columbia, Missouri 65211, United States.
ORCID-Profile: Khanh-Van Ho, Carolyn J Anderson
Förderung
- NCI NIH HHS
- Division of Cancer Prevention, National Cancer Institute
- University of Missouri
Zitieren
APA
Li, L., Wirrick, A., Pun, M. D., Lovingier, C. L., Gallazzi, F., Fong, C. O. Y., Watkinson, L., Carmack, T. L., Rodgers, M., Tucker, K., Ho, K. V., & Anderson, C. J. (2025). Effect of Click Chemistry Linkages on the Biological Behavior of Albumin-Binding 177 Lu-DOTAGA-pIBA-LLP2A Analogues Targeting Melanoma. Bioconjugate Chemistry. https://doi.org/10.1021/acs.bioconjchem.5c00277
Vancouver
Li L, Wirrick A, Pun MD, Lovingier CL, Gallazzi F, Fong COY, et al. Effect of Click Chemistry Linkages on the Biological Behavior of Albumin-Binding 177 Lu-DOTAGA-pIBA-LLP2A Analogues Targeting Melanoma. Bioconjugate Chemistry. 2025. doi:10.1021/acs.bioconjchem.5c00277
BibTeX
@article{Li2025,
author = {Li, Longbo and Wirrick, Aidan and Pun, Michael D and Lovingier, Christine L and Gallazzi, Fabio and Fong, Cyril O Y and Watkinson, Lisa and Carmack, Terry L and Rodgers, Mikayla and Tucker, Katherine and Ho, Khanh-Van and Anderson, Carolyn J},
title = {Effect of Click Chemistry Linkages on the Biological Behavior of Albumin-Binding 177 Lu-DOTAGA-pIBA-LLP2A Analogues Targeting Melanoma},
journal = {Bioconjugate Chemistry},
year = {2025},
doi = {10.1021/acs.bioconjchem.5c00277}
}
EUVIMED